Complications | TEG group (N = 21) | aPTT group (N = 21) | P value* |
---|---|---|---|
Patients with any bleeding, N (%) | 10 (47.6) | 15 (71.4) | 0.21 |
Site of bleeding#, N (%) | |||
CNS | 0 (0) | 0 (0) | – |
Gastrointestinal tract | 3 (14.3) | 1 (4.8) | 0.61 |
Vascular catheters insertion site | 4 (19.0) | 7 (33.3) | 0.48 |
ECMO cannula insertion site | 5 (23.8) | 5 (23.8) | 1.0 |
Mucosal bleeding (oral, nasal, airways) | 6 (28.6) | 10 (47.6) | 0.34 |
Surgical site (including tracheostomy) | 0 (0) | 6 (28.6) | 0.02 |
Urinary tract | 2 (9.5) | 5 (23.8) | 0.41 |
Severity of bleeding (bleed type) | 0.46 | ||
Type 0, N (%) | 11 (52.38) | 9 (42.86) | |
Type 1, N (%) | 1 (4.76) | 3 (14.29) | |
Type 2, N (%) | 8 (38.10) | 5 (23.81) | |
Type 3, N (%) | 1 (4.76) | 3 (14.29) | |
Type 4, N (%) | 0 (0.00) | 1 (4.76) | |
Patients with any thrombosis, N (%) | 4 (19.0) | 4 (19.0) | 1.0 |
Site of thrombosis, N (%) | |||
Deep venous thrombosis (ECMO cannula-related) | 2 (9.5) | 3 (14.3) | 1.0 |
Vascular catheter-related thrombosis | 1 (4.8) | 1 (4.8) | 1.0 |
ECMO cannula occlusion | 1 (4.8) | 0 | 1.0 |
RBC transfused (ml/day/patient) | 198 (37–330) | 203 (155–247) | 0.74 |
FFP transfused (ml/day/patient) | 0 (0–79) | 0 (0–0) | 0.54 |
Platelet transfused (ml/day/patient) | 0 (0–61) | 0 (0–0) | 0.28 |